Efficacy and safety of the BNT162b2 mRNA COVID-19 vaccine in participants with a history of cancer: subgroup analysis of a global phase 3 randomized clinical trial
Titel:
Efficacy and safety of the BNT162b2 mRNA COVID-19 vaccine in participants with a history of cancer: subgroup analysis of a global phase 3 randomized clinical trial
Auteur:
Thomas, Stephen J. Perez, John L. Lockhart, Stephen P. Hariharan, Subramanian Kitchin, Nicholas Bailey, Ruth Liau, Katherine Lagkadinou, Eleni Türeci, Özlem Şahin, Ugur Xu, Xia Koury, Kenneth Dychter, Samuel S. Lu, Claire Gentile, Teresa C. Gruber, William C.